Siren, L.L.C. Merus N.V. Transaction History
Siren, L.L.C.
- $1.76 Trillion
- Q1 2025
A detailed history of Siren, L.L.C. transactions in Merus N.V. stock. As of the latest transaction made, Siren, L.L.C. holds 1,043,467 shares of MRUS stock, worth $58.4 Million. This represents 2.5% of its overall portfolio holdings.
Number of Shares
1,043,467
Previous 784,412
33.03%
Holding current value
$58.4 Million
Previous $33 Billion
33.15%
% of portfolio
2.5%
Previous 1.46%
Shares
3 transactions
Others Institutions Holding MRUS
# of Institutions
195Shares Held
62.2MCall Options Held
355KPut Options Held
96.5K-
Wellington Management Group LLP Boston, MA4.72MShares$264 Million0.04% of portfolio
-
Commodore Capital LP New York, NY4.47MShares$251 Million18.43% of portfolio
-
Rtw Investments, LP New York, NY4.17MShares$234 Million2.88% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.37MShares$189 Million7.27% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.17MShares$178 Million3.38% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.57B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...